Medicx Media Solutions (https://medicxmedia.com), the leading U.S. data-driven healthcare media analytics company, today announced the issuance of U.S. Patent No. 10,262,761 to Founder & CEO Michael Weintraub for his technical invention of the apparatus and methods for the delivery of advertising based on the prevalence of a healthcare condition in hyper-local geographic areas across the U.S.
SCOTTSDALE, Ariz., April 18, 2019 /PRNewswire/ -- Medicx Media Solutions (https://medicxmedia.com), the leading U.S. data-driven healthcare media analytics company, today announced the issuance of U.S. Patent No. 10,262,761 to Founder & CEO Michael Weintraub for his technical invention of the apparatus and methods for the delivery of advertising based on the prevalence of a healthcare condition in hyper-local geographic areas across the U.S. To learn more about Medicx Media Solutions, visit: https://medicxmedia.com/approach/ The patent relates to the company's Micro-Neighborhood® targeting platform that includes:
"After more than ten years of continued success, recognition on this level further confirms the uniqueness, relevance and power of the Medicx Micro-Neighborhood® targeting platform. This patent proves that the granularity of our data and the ability to customize our audience segments with near precision, in a HIPAA compliant manner, delivers far more efficient and effective campaign outcomes with stronger ROI. That is why we are the market leaders," said Medicx Founder & CEO Michael Weintraub. About Medicx Media Solutions ¹A re-identification risk determination was performed pursuant to the HIPAA Privacy Rule Expert Determination standard and the determination concluded that, in the given data use and disclosure context, the risk of re-identification was very small.
SOURCE Medicx Media Solutions |